Wangxi Hai

Dr. Wangxi Hai


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 March 2022 in Frontiers in Immunology
Verified
Journal Article
Open access
NLNing Li
Ning Li
YLYusi Li
Yusi Li
JHJiawei Hu
Jiawei Hu
YWYicheng Wu
Yicheng Wu
JYJie Yang
Jie Yang
LJLiting Jiang
Liting Jiang
Background: Primary Sjogren’s syndrome (pSS) is a slowly progressive, inflammatory autoimmune disease characterized by lymphocytic infiltration into salivary and lacrimal glands. It becomes more recognized that morphology alterations of epithelial mitochondria are involved in altered cellular bioenergetics in pSS patients. The integrated analysis of the mitochondrial role in the pathogenesis and aberrant immune microenvironment in pSS remains unknown.Methods: The mitochondria-related genes and gene expression data were downloaded from the MitoMiner, MitoCarta, and NCBI GEO databases. We performed novel transcriptomic analysis and constructed a network between the mitochondrial function and immune microenvironment in pSS-salivary glands by computer-aided algorithms. Subsequently, real-time PCR was performed in clinical samples in order to validate the bioinformatics results. Histological staining and transmission electron microscopy (TEM) were further studied on labial salivary gland samples of non-pSS and pSS patients characterized for mitochondria-related phenotypic observation in the different stages of the disease.Results: The bioinformatic analysis revealed that the expression of several mitochondria-related genes was altered in pSS. Quantitative real-time PCR showed that four hub genes, CD38, CMPK2, TBC1D9, and PYCR1, were differentially expressed in the pSS clinical samples. These hub genes were associated with the degree of immune cell infiltration in salivary glands, the mitochondrial respiratory chain complexes, mitochondrial metabolic pathway in gluconeogenesis, TCA cycle, and pyruvate/ketone/lipid/amino acid metabolism in pSS. Clinical data revealed that the gene expression of fission (Fis1, DRP1, and MFF) and fusion (MFN1, MFN2, and OPA1) was downregulated in pSS samples, consistent with the results from the public validation database. As the disease progressed, cytochrome c and Bcl-2 proteins were regionally distributed in salivary glands from pSS patients. TEM revealed cytoplasmic lipid droplets and progressively swollen mitochondria in salivary epithelial cells.Conclusion: Our study revealed cross talk between mitochondrial dysfunction and the immune microenvironment in salivary glands of pSS patients, which may provide important insights into SS clinical management based on modulation of mitochondrial function.

6 April 2023 in iScience
Verified
Journal Article
Open access
NLNing Li
Ning Li
YYYulin Ye
Yulin Ye
YWYicheng Wu
Yicheng Wu
LLLei Li
Lei Li
JHJiawei Hu
Jiawei Hu
LJLiting Jiang
Liting Jiang
Aging-related salivary dysfunction typically causes reduced saliva volumes, which leads to debilitating consequences, even affecting patient quality of life. Understanding the respective clinicopathological characteristics and molecular mechanisms underlying salivary gland functioning during aging is vital for therapeutic purposes. Here, we provide a detailed atlas of the salivary gland microenvironment during aging, and we identified several phenotypes characteristic of aging salivary glands, including acini atrophy, increased inflammatory cells, altered immune responses, and accumulation of lysosomes and autophagosomes in aging cells, which may reflect progressive degeneration of salivary gland function. Furthermore, our analyses suggested significant enrichment of metabolic pathways in aging glands. Our results revealed complex cellular cross-talk among aging acinar cells, inflammatory factors, and immune responses. A natural aging animal model was established to verify these findings. This study provides mechanistic insights into age-related clinicopathogenesis, important implications for early diagnosis, and identification of new targets for improving salivary gland dysfunction.

1 March 2024 in Radiology
Verified
Journal Article
Closed access
MZMin Zhang
Min Zhang
HMHuanyu Meng
Huanyu Meng
QZQinming Zhou
Qinming Zhou
HCHangxing Chunyu
Hangxing Chunyu
LHLu He
Lu He
Sheng ChenSheng Chen
Sheng Chen
Background Translocator protein (TSPO) PET has been used to visualize microglial activation in neuroinflammation and is a potential imaging tool for detecting autoimmune encephalitis (AIE). Purpose To compare the detection rate between TSPO radioligand fluorine 18 (18F) DPA-714 PET and conventional MRI and assess the relationship between 18F-DPA-714 uptake and clinical features in participants with AIE. Materials and Methods Healthy volunteers and patients with AIE were enrolled in this prospective study between December 2021 and April 2023. All participants underwent hybrid brain 18F-DPA-714 PET/MRI and antibody testing. Modified Rankin scale scoring and AIE-related symptoms were assessed in participants with AIE. Positive findings were defined as intensity of 18F-DPA-714 uptake above a threshold of the mean standardized uptake value ratio (SUVR) plus 2 SD inside the corresponding brain regions of healthy controls. The McNemar test was used to compare the positive detection rate between the two imaging modalities; the independent samples t test was used to compare continuous variables; and correlation with Bonferroni correction was used to assess the relationship between 18F-DPA-714 uptake and clinical features. Results A total of 25 participants with AIE (mean age, 39.24 years ± 19.03 [SD]) and 10 healthy controls (mean age, 28.70 years ± 5.14) were included. The positive detection rate of AIE was 72% (18 of 25) using 18F-DPA-714 PET compared to 44% (11 of 25) using conventional MRI, but the difference was not statistically significant (P = .065). Participants experiencing seizures exhibited significantly higher mean SUVR in the entire cortical region than those without seizures (1.23 ± 0.21 vs 1.15 ± 0.18; P = .003). Of the 13 participants with AIE who underwent follow-up PET/MRI, 11 (85%) demonstrated reduced uptake of 18F-DPA-714 accompanied by relief of symptoms after immunosuppressive treatment. Conclusion 18F-DPA-714 PET has potential value in supplementing MRI for AIE detection. Clinical trial registration no. NCT05293405 © RSNA, 2024 Supplemental material is available for this article. See also the editorial by Zaharchuk in this issue.

21 June 2024 in ACS Applied Nano Materials
Verified
Journal Article
Closed access
YJYifei Jiang
Yifei Jiang
AWAnqi Wang
Anqi Wang
QWQinghe Wu
Qinghe Wu
GJGuoping Jia
Guoping Jia
WHWangxi Hai
Wangxi Hai
Chunfu ZhangChunfu Zhang
Chunfu Zhang

4 July 2025 in Chemical & Biomedical Imaging
Verified
Journal Article
Open access
RLRou Li
Rou Li
JLJie Li
Jie Li
SXShuai Xue
Shuai Xue
DLDanni Li
Danni Li
ZYZixin Yang
Zixin Yang
XLXiao Li
Xiao Li
Angiotensin-converting enzyme 2 (ACE2) has been identified as a biomarker and a promising therapeutic target in several diseases. The noninvasive visualization of in vivo ACE2 mapping is urgent for disease guidance and treatment assessment. A radioimmuno assay method adapting to the RBD peptide library was proposed here to screen a high ACE2-specific peptide sequence as the targeting molecule. Derived from the constructed RBD peptide libraries of the dominant Omicron variants (BA.1, BA.2, and BA.5), the superior peptide was high-throughput screened through the binding rate to the HEK293-hACE2 cell and verified by the molecular docking with ACE2. Further, biodistribution studies were conducted through 125I-based SPECT imaging. The DOTA-modified derivant was labeled with Ga-68 to enable ACE2-targeted PET imaging. The peptide 505HQPYRVVVLSFELLH519 (named as Omi-X) showed a superior ACE2 binding via molecular docking and cellular assays. 125I-labeled Omi-X SPECT imaging demonstrated the high ACE2-specificity and binding retention in K18-hACE2 mice, together with an ideal performance in labeling stability and flexibility. The ACE2-targeted PET imaging tracers68Ga-DOTA-Omi-X realized the ACE2 mapping and further applicability in RAAS-related diseasescardiac hypertrophy, intuitively reflecting the ACE2 expression and regulating role. This natural evolution-guided approach not only enabled a noninvasive visualization of ACE2 but also established a paradigm for developing targeted therapies by leveraging viral-host adaptation mechanisms. Our work bridged natural evolution and target molecule screening and offered imaging tools for RAAS pathophysiology, investigation, and precision diagnostics.

8 July 2024 in Analytical Chemistry
Verified
Journal Article
Closed access
XLXinmiao Lu
Xinmiao Lu
XDXiaohui Deng
Xiaohui Deng
FKFei Kong
Fei Kong
WHWangxi Hai
Wangxi Hai
QLQuanyong Luo
Quanyong Luo